These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30393117)

  • 61. miR-124 and miR-506 inhibit colorectal cancer progression by targeting DNMT3B and DNMT1.
    Chen Z; Liu S; Tian L; Wu M; Ai F; Tang W; Zhao L; Ding J; Zhang L; Tang A
    Oncotarget; 2015 Nov; 6(35):38139-50. PubMed ID: 26497367
    [TBL] [Abstract][Full Text] [Related]  

  • 62. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.
    Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T
    Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MiR-26a downregulates retinoblastoma in colorectal cancer.
    López-Urrutia E; Coronel-Hernández J; García-Castillo V; Contreras-Romero C; Martínez-Gutierrez A; Estrada-Galicia D; Terrazas LI; López-Camarillo C; Maldonado-Martínez H; Jacobo-Herrera N; Pérez-Plasencia C
    Tumour Biol; 2017 Apr; 39(4):1010428317695945. PubMed ID: 28443472
    [TBL] [Abstract][Full Text] [Related]  

  • 64. miR-23a promotes the transition from indolent to invasive colorectal cancer.
    Jahid S; Sun J; Edwards RA; Dizon D; Panarelli NC; Milsom JW; Sikandar SS; Gümüs ZH; Lipkin SM
    Cancer Discov; 2012 Jun; 2(6):540-53. PubMed ID: 22628407
    [TBL] [Abstract][Full Text] [Related]  

  • 65. LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers.
    Yu H; Yue X; Zhao Y; Li X; Wu L; Zhang C; Liu Z; Lin K; Xu-Monette ZY; Young KH; Liu J; Shen Z; Feng Z; Hu W
    Nat Commun; 2014 Oct; 5():5218. PubMed ID: 25323535
    [TBL] [Abstract][Full Text] [Related]  

  • 66. TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression.
    Wang S; Zhang Y; Huang J; Wong CC; Zhai J; Li C; Wei G; Zhao L; Wang G; Wei H; Zhao Z; Yu J
    Cancer Res; 2019 Aug; 79(16):4086-4098. PubMed ID: 31239268
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Overexpression of microRNA-30b improves adenovirus-mediated p53 cancer gene therapy for laryngeal carcinoma.
    Li L; Wang B
    Int J Mol Sci; 2014 Oct; 15(11):19729-40. PubMed ID: 25356506
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Altered p53 regulation of miR-148b and p55PIK contributes to tumor progression in colorectal cancer.
    Wang G; Cao X; Lai S; Luo X; Feng Y; Wu J; Ning Q; Xia X; Wang J; Gong J; Hu J
    Oncogene; 2015 Feb; 34(7):912-21. PubMed ID: 24632606
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epigenetically regulated miR-1247 functions as a novel tumour suppressor via MYCBP2 in methylator colon cancers.
    Liang J; Zhou W; Sakre N; DeVecchio J; Ferrandon S; Ting AH; Bao S; Bissett I; Church J; Kalady MF
    Br J Cancer; 2018 Nov; 119(10):1267-1277. PubMed ID: 30318507
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tumor suppressor Parkin induces p53-mediated cell cycle arrest in human lung and colorectal cancer cells.
    Jung BC; Kim SH; Cho Y; Kim YS
    BMB Rep; 2023 Oct; 56(10):557-562. PubMed ID: 37679297
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Changes in miR-222 expression, DNA repair capacity, and MDM2-p53 axis in association with low-dose benzene genotoxicity and hematotoxicity.
    Wang TS; Tian W; Fang Y; Guo KR; Li AQ; Sun Y; Wu HT; Zheng GQ; Feng NN; Xing CH; Au WW; Sun DY; Xia ZL
    Sci Total Environ; 2021 Apr; 765():142740. PubMed ID: 33071125
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Suppression of autophagy promotes fibroblast activation in p53-deficient colorectal cancer cells.
    Inoue T; Hayashi Y; Tsujii Y; Yoshii S; Sakatani A; Kimura K; Uema R; Kato M; Saiki H; Shinzaki S; Iijima H; Takehara T
    Sci Rep; 2021 Sep; 11(1):19524. PubMed ID: 34593902
    [TBL] [Abstract][Full Text] [Related]  

  • 73. RNF43 interacts with NEDL1 and regulates p53-mediated transcription.
    Shinada K; Tsukiyama T; Sho T; Okumura F; Asaka M; Hatakeyama S
    Biochem Biophys Res Commun; 2011 Jan; 404(1):143-7. PubMed ID: 21108931
    [TBL] [Abstract][Full Text] [Related]  

  • 74. 7-hydroxyfrullanolide, isolated from Sphaeranthus indicus, inhibits colorectal cancer cell growth by p53-dependent and -independent mechanism.
    Pandey P; Singh D; Hasanain M; Ashraf R; Maheshwari M; Choyal K; Singh A; Datta D; Kumar B; Sarkar J
    Carcinogenesis; 2019 Jul; 40(6):791-804. PubMed ID: 30535334
    [TBL] [Abstract][Full Text] [Related]  

  • 75. PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53.
    Wang W; Wei J; Zhang H; Zheng X; Zhou H; Luo Y; Yang J; Deng Q; Huang S; Fu Z
    Cell Death Dis; 2021 Jun; 12(6):605. PubMed ID: 34117220
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell.
    Shin YJ; Kim MS; Kim MS; Lee J; Kang M; Jeong JH
    Cancer Biol Ther; 2013 Mar; 14(3):213-21. PubMed ID: 23255232
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Choline-induced SLC5A7 impairs colorectal cancer growth by stabilizing p53 protein.
    Yin Y; Jiang Z; Fu J; Li Y; Fang C; Yin X; Chen Y; Chen N; Li J; Ji Y; Su X; Qiu M; Huang W; Zhang B; Deng H; Dai L
    Cancer Lett; 2022 Jan; 525():55-66. PubMed ID: 34562520
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cullin-9/p53 mediates HNRNPC degradation to inhibit erastin-induced ferroptosis and is blocked by MDM2 inhibition in colorectal cancer.
    Yang L; WenTao T; ZhiYuan Z; Qi L; YuXiang L; Peng Z; Ke L; XiaoNa J; YuZhi P; MeiLing J; QingYang F; GuoDong H; YueXiang W; JianMin X
    Oncogene; 2022 Jun; 41(23):3210-3221. PubMed ID: 35505093
    [TBL] [Abstract][Full Text] [Related]  

  • 79. miR-34: from bench to bedside.
    Agostini M; Knight RA
    Oncotarget; 2014 Feb; 5(4):872-81. PubMed ID: 24657911
    [TBL] [Abstract][Full Text] [Related]  

  • 80. EDDiting p53 levels.
    Warmerdam DO
    Cell Cycle; 2012 Mar; 11(5):839. PubMed ID: 22356749
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.